BioNTech

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

A safety monitoring system flagged that U.S. drugmaker Pfizer Inc (PFE.N) and German partner BioNTech's updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to…

15 January 2023

A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier/File Photo

Pfizer/BioNTech Seek FDA Nod For New COVID Boosters For Children

Pfizer Inc (PFE.N) and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through…

26 September 2022

A healthcare worker prepares to administer a Pfizer/BioNTEch coronavirus disease (Covid-19) vaccine at The Michener Institute, in Toronto, Ontario on December 14, 2020. - Ontario, Canada's most populous province and one of the hardest hit by the pandemic, had 1,940 new cases and 23 deaths on Monday. The province is expected to give its next doses to nursing home workers as a priority, according to media reports. (Photo by CARLOS OSORIO / POOL / AFP) (Photo by CARLOS OSORIO/POOL/AFP via Getty Images)

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

It’s undoubtedly a coincidence, but two commentators I find most thoughtful and trustworthy both weighed in Wednesday on the question of whether the Food and Drug Administration should just go ahead…

Michael Hiltzik 25 July 2021

Popular
Editor's Pick

Sara Padovan

Politics

The flaw in Trump’s 'dealmaking' Middle East peace plan

16 October 2025

Rushed deals and a disregard for root problems provide a flimsy foundation for sustainable peace

Abdullah F. Alrebh

Peter Reynolds

Business & Economy

The fight for resources could determine who 'wins' the war in Sudan

17 October 2025

The army and the RSF rely on the assets at their disposal to sustain governance and fund their war efforts, while trying to win over the international community by seizing larger swathes of Sudan

Sharif Mohammad

Russian President Vladimir Putin and Syrian interim president Ahmed al-Sharaa hold a meeting at the Grand Kremlin Palace in Moscow on October 15, 2025.

Alexander Zemlianichenko / AFP

Politics

Unpacking Sharaa's diplomatic overture to Putin

16 October 2025

In Moscow, Syria's new president said he wants to restore and redefine relations with Russia—a former foe. But is this a genuine olive branch or a message to Washington?

Samer Elias